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INTRODUCTION: 
There are various techniques to anaesthetise a patient.  It is really a divine 
venture to alleviate the pain.  Regional  techniques  are  now a days  becoming  
more   and  more  popular    because  it  has  its  own  advantages  of   providing  
anaesthesia  and  pain  relief  and  relaxation  required  for  the  surgery  
pertaining  to  the  area  required  only  without  unnecessarily  blocking  the  
other  sites  and  avoiding  unnecessary  complications   which  can  be  better  
avoided  just  by  reducing  the  poly pharmacy   as  in general  anaesthesia   
which  is  not  always  needed  or  better  to  be  said   it  is  unnecessary  for  all  
the  cases. 
The  generalized   thought  of  general  anaesthesia  for  any  surgery  has  
been  totally  out dated  now a days.  Thanks  to  the  regional  anaesthesia  as  
such  because  it  is  feasible   many  a time  and  has  won  very  good  patient  
compliance  also. 
Among  the  regional  techniques  we  are  going  to  focus  mainly  on  
the  regional  anaesthesia  for  the  upper  limb   that  is  the  brachial  plexus  
blockade. 
There  are  various  available  approaches  and  techniques  in  brachial  
plexus  blockade. Among  them  this  study  concentrates  on   the  supra  
clavicular  technique. 
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In  the  supra clavicular  technique  a  huge  number  of  studies  have  
been  done  at  various  angles. Many  studies  have  concentrated  on  the  local  
anaesthetics  and  its  varying  concentrations  used   and  their  respective  
effects  upon  the  patients. 
ADJUVANTS: 
THESE  ARE  NOTHING  BUT  THE  DRUGS  WHICH ARE  ADDED  
TO  LOCAL  ANAESTHETICS  IN  ORDER TO  
• HASTEN  THE  ONSET  OF  BLOCKADE OR   
• TO  PROLONG  THE  DURATION  OF  BLOCK  OR   
• TO  IMPROVE  THE  QUALITY  OF  BLOCKADE. 
Humpty  number  of  studies  have  been  conducted  upon  using   
various   and  different  classes  of  drugs   as  adjuvants  in  brachial  plexus  
block. To  enumerate  upon  the  drugs : 
• Epinephrine 
• Sodium bicarbonate 
• Clonidine  
• Dexamethasone 
• Tramadol 
• Dexmedetomidine 
• Butorphanol 
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• Buprenorphine 
• Fentanyl 
• Alfentanyl 
And  so  on  . Each  and  every  drug  
behaved in  a  different  fashion. 
[1,2,3,4] 
But  among  all  those  studies  there  have  not  been  any  study  focused  on  
comparison  between  buprenorphine  and  clonidine. 
Hence   this  special   study  is  focused  to  contrast   the effects  of   
buprenorphine  and  clonidine  as  analgesic adjuvants to bupivacaine  in  
supraclavicular brachial  plexus blockade. 
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AIM  &  OBJECTIVES 
 
AIM OF THIS PARTICULAR STUDY: 
 
To  compare   the  effectiveness  of  adding buprenorphine  and clonidine 
as adjuvants to 0.3% bupivacaine in supraclavicular brachial plexus blockade. 
 
OBJECTIVES: 
                      
                To evaluate  
a) The onset time for sensory and motor blockade, 
b) The time for complete motor and sensory blockade 
c) The total duration of sensory and motor blockade 
d) Adverse effects 
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REALITY BEHIND BRACHIAL PLEXUS: [40] 
Brachial  plexus  - one which  supplies  nerves  to  the  upper  limb. This    
is  formed  by  the  ventral    divisions  in  the  5 TH   to  the  8 TH   Cervical  
plus  the     1 ST   thoracic  nerves, with its  contributions  from  the    4 th   
cervical   and  the    2 nd    thoracic  roots. 
Then   roots join to form the 
• Superior trunk 
• Middle  trunk 
• Inferior  trunk 
         These trunks now divide into divisions namely 
• Anterior division 
• Posterior division 
The  contained three  posterior  divisions  unite  to  form    posterior  
cord. The  major  branches  of  this  posterior  cord   : ---  AXILLARY, 
                                                                    also  the  RADIAL  NERVE. 
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The  upper  two  of the  anterior  divisions    --  is  derived   lateral  
cord.  major  branches  of  the  lateral  cord  are  including  : 
MUSCULO CUTANEOUS  N.,     also   LATERAL  ROOT  
contribution to   MEDIAN  NERVE. 
                   Lowest  anterior  division is   forming  the  medial  cord.    
Medial cord  then  provides: 
       MEDIAL  ROOT  contribution to     MEDIAN   NERVE, 
terminating as   --  ULNAR   NERVE. 
                 sympathetic  contributions  to  this  plexus  are  being 
derived   of    so    called    MIDDLE  CERVICAL  GANGLION,  also  
STELLATE  GANGLION. [5]  
 
 
VARIOUS TECHNIQUES OF BRACHIAL PLEXUS BLOCK: [6-10] 
Four classic routes had been described for blocking the brachial plexus 
namely: 
• Paravertebral – kappis method 
• Axillary – Hirschel method 
• Infraclavicular – Louis,Bazi method 
• Supra clavicular – Kulenkampf  method 
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The first two techniques have been virtually abandoned now days. But the 
INFRACLAVICULAR  AND  SUPRACLAVICULAR  TECHNIQUES  are  
seen to be  achieving   a  replenishing  surge  in  their  use  now a days that  too   
with  the  aid  of  ultrasound  imaging. 
  The  use  of    the ultrasound  imaging  is  directing  the  anaesthesiologist  
towards  the  targeted  nerve  providing  a  live  guidance  with   concurrent  
visualization  of   the   important  vascular  plus  other  vital  structures  situated 
there. 
This    is  being  used  in this  era  with  increasing  frequency   in  aiding  
the  performance  of  various  established  regional  blocks  --  brachial  plexus, 
femoral  and  sciatic  nerves. 
The  perivascular  techniques   of  brachial  plexus  block  elaborated  by 
WINNIE  & COLLINS by  axillary,  inter scalene  or   the subclavian  approach  
are  found to  be  the  most  commonly  used  techniques.  Each is known for its 
advantages and disadvantages. 
When  there is  an  advantage  or  significant  benefit  in  a  Technique,  it  
is  a  well  aware   fact   also  that  that  kind  of  advantage  may  also  be  
overshaded  or  else  set   beside  that  of  the  disadvantages  also  which  is  to  
be  acceptable. 
 
 
8 
 
 
SUPRACLAVICULAR BLOCK: 
ADVANTAGES: 
• Most  compactly  arranged  form of  nerve  fibres 
• Most  intensive  blockade achieved 
• Smaller  volume being  required 
• Quicker onset  achieved 
• All of the nerves are  being reliably blocked 
• Can be performed also if arm is immobilized 
DISADVANTAGES: 
• Demonstrable  PARAESTHESIAS  REQUIRED WHICH IS 
UNPLEASANT FOR THE PATIENT 
• 0.5 – 6% of pneumothorax  incidence seen 
• 40-60% phrenic nerve blockade  seen 
• 70-90% stellate ganglion blockade  recorded 
• Possibility of neuritis  also seen. 
 
INTERSCALENE BLOCK : 
ADVANTAGES: 
• This is Ideal for shoulder surgery 
• Cervical plexus can  also be blocked by this method 
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• Can  be  performed  even when the  arm is immobilized 
• Clear landmarks appreciated 
• Lower volume sufficient for block 
• Lesser chance of pneumothorax than in  supraclavicular block 
 
DISADVANTAGES: 
• Lower trunk anaesthesia  may  be missed here 
• May also block phrenic nerve, vagus, recurrent laryngeal nerve, also 
cervical sympathetic nerves. 
• Inadvertent entry of drug to other sites and epidural, subdural, spinal 
anaesthesia have been seen 
• Intra vascular injection into vertebral artery may  also occur. 
 
AXILLARY BLOCK: 
ADVANTAGES: 
•  Provides Excellent anaesthesia for forearm and hand 
•  Performance wise Easy technique 
• Easily  demonstrable  landmark 
• Safest of all the techniques 
• Easiest to do in paediatric group 
• Paraesthesia  here is not necessary 
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DISADVANTAGES: 
• Insufficient for the  shoulder and   the  upper arm surgery 
• To perform this technique , abduction of the arm  is  required 
• Intra vascular injection may be seen 
• Haematoma formation 
 
PERIVASCULAR SUBCLAVIAN BLOCKADE: 
ADVANTAGES: 
• EASY LAND MARKS TO IDENTIFY this. 
• Can be  done  even when  the patient’s arm is immobilized 
• Smaller volume is being needed compared to axillary block 
• Lesser chances  of leaving  the lower trunk unblocked 
 
DISADVANTAGES: 
• TO ENSURE THE SUCCESS of  this   block, paraesthesia needed 
• Pneumothorax  may be seen 
• With large volumes of local anaesthetic  this  method  may  also  block  
phrenic  nerve, recurrent laryngeal and  also cervical sympathetic nerves  
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Review of Literature                  
Various     Biochemical studies performed to purify the opioid receptor 
protein but not successful. Since the early ages of  1990s,  many molecular 
biologic studies were elucidating  the molecular structures, signal transduction 
mechanisms in  the opioid receptors. 
Four very different cDNAs were isolated as the members of this opioid 
receptor family. Three receptors of them corresponding to the 
pharmcacologically elaborated µ-, δ-, and κ-opioid receptors.  And the fourth 
receptor was not binding with   the opioid ligands with higher affinity.  Then, a  
newer peptide namely  nociceptin / orphanin FQ  then  identified as the 
endogenous agonist of this  fourth member of this  opioid receptor family.  The 
µ-receptors are also located in both the brain and the spinal cord and is 
mediating   a various number of   pharmacologic actions of opioids.  
Further the pharmacological classification of this µ-receptor is as µ1, µ2, 
and µ3 which has been proposed.  The post-translational modification of this µ-
receptor was the molecular basis of the µ-receptor subtypes. [11-14] 
The   Opioids   also produce analgesia through a peripheral mechanism.  
The  Immune cells infiltrating the  inflammatory site also  release endogenous 
opioid-like substances  which  act on opioid receptors which is  located on the 
primary sensory neuron. [15, 16, 17, 18, 19, 20] 
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Buprenorphine   is  found  to  produced   variable  affection  of  the  
respiratory  adequacy    at   a  dose higher than 3.0 µg/kg to   50% of baseline, in 
opposition  to fentanyl, in which there is  dose-dependent respiratory depression  
and  resulting  in apnea at doses higher than 2.9 µg/kg. [21] 
Sarkar D et al ,[22]  compared the  effects  of  adding  buprenorphine  
and  fentanyl in  supra  clavicular  block  in  a      controlled    study   of     75   
comparable  adults  conducted  over  a period  of  one  year allocated  into  3   
equal  groups  with  group  A as 2 % lignocaine  10 ml with adrenaline +  0.5 5 
bupivacaine 20 ml + distilled  water  1o ml  and  group  B   has  added  0.3 mg 
of  Buprenorphine  and  group C  with  added  50 mcg  fentanyl  to the  same  
drug  mixture  as  group  A . 
He   has  concluded  that  the  addition  of  fentanyl  had  no  significant  
benefits  on  the  duration  of  analgesia  but  the  addition  of  buprenorphine  
has  significantly   increasing    time   of   devoid  of   the  pain that  is  analgesia  
to    nearly    1.5  times  that  of  the  control  group and  has  observed  no  
significant  side  effects  of  adding  buprenorphine. [22] 
Ashok   jadan  et al  [23] did a study  with addition of  buprenorphine  as  
adjuvant  to  30 ml  of  0.3 % bupivacaine and   he  observed   that   the  
addition   of   3  mcg / kg  of  buprenorphine  in   brachial  plexus  method  of   
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anaesthesia     for   the    ortho     surgery  --  the  time  to obtain  complete  level 
of sensory blockade  is   lengthened  but  hastens    onset    to    motor  block  
time.  It improves the quality   in    block, lengthens the   pain free  time  that is   
analgesia  but  without  affecting  the  duration  of  motor  blockade.  
Popping et al. [24] in  his  meta analysis of  the   randomized trials   had  
showed that there  is    good  pleasing  actions  in  clonidine in the  time  of  pain  
free  period -.  They   noticed    that there is prolongation of motor block which   
was higher while the same drug   then     mixed with the   bupivacaine as 
compared to ropivacaine.  The least effect is being  noted with prilocaine. 
                      
There  are no published studies which compare   the  effects  of  clonidine  
and   buprenorphine  as  adjuvants  in  supraclavicular block, that  too with   
0.3 % bupivacaine.  Hence  we  have chosen  this  study  of  comparing  the  
effects  of  clonidine and buprenorphine  as  adjuvants  in    the  30  ml  of  0.3%  
bupivacaine in  supraclavicular  block. 
TECHNIQUES NEEDED TO LOCALISE THE NERVES: 
Various   tactics    are    differently   said  to  catch  hold   of  identifying  
target,   that   includes    “pops,”   also  elicitation of one or more paresthesias,  
also perivascular or transarterial injection,  measured  electrical stimulation, and   
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also  field infiltration.  Now days, direct imaging by ultrasonography, the 
fluoroscopy, the computed tomography (CT), and the   magnetic resonance 
imaging (MRI) has also been used. Although there is   no definitive study which 
has   identified the best method guiding for needle placement, generalities are 
possible.  The elicitation of a paresthesia is appearing to be equivalent to the 
electrical stimulation.  
The Success rates and the onset times of paresthesia and nerve 
stimulation techniques are now   further improved if the   multiple injections are 
performed.  The Transarterial injection is variably successful and a two-
injection transarterial technique is   also comparable to  the single-injection 
paresthesia or nerve stimulator techniques. 
The success rate using a fascial pop or click is variable, it   also may be 
much more reliable in pediatric patients than in the   adults. [40] 
           Now a days    the   peripheral techniques are   being  performed under 
ultrasound guidance  moreover  with or without confirmation of needle 
placement by  the  electrical stimulation. Both  the  approaches involve  the  
visualization of the  local  anesthetic  spread  during  the  injection. [41] 
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The   Ultrasound images of the distribution of  the local anesthetic  
provided  the  clinicians with the   visualization of successful blocks  and  also   
have  documented   why  are  the    single-injection techniques  less   reliable. 
[42] 
The risk of intravascular injection of large-volume   local anesthetic may 
be reduced by experienced ultra-sonographers’ hands.  
Supraclavicular Block  
CLINICAL USES: 
Indications for supraclavicular block are the operations on the elbow, 
forearm, and hand.  The Blockade occurs at the LEVEL OF distal trunk–
proximal division level.  At this AREA, the brachial plexus is very compact and 
thus small volume of solution produces a rapid onset of reliable blockade in the 
brachial plexus.  Another additional advantage is that this block can also be 
performed with the patient's arm in any position. 
Ensured supraclavicular blockade requires elicitation of a paresthesia or a 
motor response.  The classic block may be appearing somewhat difficult to 
describe and to demonstrate.  A proposed modification of the technique, the so 
named     plumb-bob approach, decrease the complications and     is  simplifying 
the concept of this block. 
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TECHNIQUE OF BLOCK: 
Several anatomic points are important for performance of the 
supraclavicular approach.  The   plexus    - its three trunks are being clustered 
vertically overlying the   rib number   one    cephalad and behind the artery of 
subclavian, that   can often be palpated in a slender, relaxed patient.  
This neurovascular bundle lying inferior to the clavicle at about the 
midpoint.  The first rib acting as a medial barrier to needle reaching the pleural 
dome and it is short, broad, and flat, having an anteroposterior orientation at the 
site of the plexus. 
Now   ask  and  instruct  the  patient  to   lie  in  the  couch  in  the  normal  
supine  posture  and  instruct  him  to  look  to  the  opposite  side  of   block    
intended  side    by  turning  his  head  there.  The arm  that   ought  be 
anesthetized should be adducted, then  the hand should be extended  toward the 
ipsilateral knee as far as possible.  
In this classic technique, the midpoint of   clavicle should be identified 
and marked first.  The posterior border of the sternocleidomastoid may be 
palpated easily when the patient is asked to raise the head slightly.  Then 
palpating fingers can  roll over the belly of the anterior scalene muscle  dipping  
into the interscalene groove, and  a mark should be drawn  approximately 1.5 to  
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2.0 cm  behind  the  clavicle ‘s  middle  point.  Palpation of the subclavian 
artery now at this site confirms the landmark. 
Then after appropriate preparation and also   development of a skin 
wheal, now the anesthesiologist stands at the side of the patient facing patient's 
head.  The    needle  to  do  block   is   pricked  in  this  marked  site  in  the  
downward , inward  and  behind   direction   till   we  are  getting  the    motor 
response  or   paresthesia  or the   rib  number  one   is   reached. 
While   a syringe  is attached, this exact orientation causes the needle 
shaft and syringe to lie almost parallel in a line joining the skin entry site and 
also the patient's ear. If the first rib is being  encountered without elicitation of a 
paresthesia, the needle  then can be systematically walked anteriorly and 
posteriorly over   the rib until the plexus or the subclavian artery is located .The  
Location of the artery provides a useful landmark  and  then  the needle can be 
withdrawn and reinserted  now  in a more posterolateral direction, that  
generally results in a paresthesia or motor response.  After localization of the 
brachial plexus, aspiration for blood should be done before incremental 
injections of a total volume local anaesthetic   solution of 20 to 30 ml. 
The rib is usually contacted at a needle depth of 3 to 4 cm and in an obese 
patient or in the presence of tissue distortion due to hematoma or injection of  
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solution, exact depth may exceed the length of the needle.  But, before the 
needle is advanced farther, fine   probing in the anterior and posterior directions 
must be done at the 2- to 3-cm depth if at all paresthesias are not obtained. 
Multiple  injections will improve the quality or shorten the onset of blockade. 
The modified plumb-bob approach uses same   arrangement  and  patient 
positioning, though the needle entry  is at the point where the lateral  margin  of  
neck  muscle  sterno cleido mastoid   is  inserting  into    clavicle.   
After aseptic preparation and raising of a skin wheal, a 22-gauge, 4-cm 
needle now is   inserted while mimicking a plumb-bob   as if suspended over the 
needle entry site.  Usually, a paresthesia or motor response is elicited before 
contacting WITH THE NEEDLE the first rib or artery.  
 If no paresthesia or motor response is being elicited, the needle is 
reinserted    when angling the tip of the needle upward towards head and then 
caudad in little steps until the first rib is contacted. 
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COMPLICATIONS :  
Although the block is more difficult to perform in obese patients, there 
did not appear to be an increased number of complications. The prevalence of 
pneumothorax after performing a supraclavicular block is about 0.5% to 6% and 
this diminishes with experience.  
The onset of symptoms is sometimes delayed and may take even up to 24 
hours. Routine chest x ray  after the block is not justified. The supraclavicular 
technique is best avoided when the patient is not cooperative or he cannot 
tolerate any degree of respiratory compromise due to the   underlying diseases.     
Other noted   complications include frequent phrenic nerve block (40% to 
60%), also Horner's syndrome, and neuropathy.  The scene of phrenic or 
cervical   sympathetic nerve   blockade usually   requires only reassurance.   
And    though the   nerve damage can occur, it is uncommon and normally   self-
limited. 
NERVE IMAGING STUDY WITH ULTRASOUND: [27-32] 
The Fascicles of peripheral nerves can be detected with a high-resolution 
ultrasound imaging.  The fascicular echotexture is often the most distinguishing 
feature of nerves namely “honeycomb” architecture.  More central nerves, such  
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as the cervical ventral rami, with fewer fascicles,   therefore can appear as   
monofascicular on ultrasound scans.   
One of the most powerful techniques to clinch the nerve fascicles is to 
slide a broad linear transducer   on the area of     peripheral      target   N. being     
transverse cross section view. 
Nerves can appear round, oval, or triangular.   Although nerve shape can 
be   changing     on   course, cross-sectional area is same and constant in the 
absence of major branching.  The Peripheral nerves are pathologically enlarged 
also by entrapment or in certain other neuromuscular disorders such as Charcot-
Marie-Tooth disease of type IA.  There is also some evidence to suggest that the   
patients with diabetic neuropathy are   also having enlarged peripheral nerves. 
It is true that direct nerve imaging has led to a phenomenal good   
increase in ultrasound-guided regional anesthesia, but still  the identification of 
other nearby structures like  the   fascia and other connective tissue    is     
critical in this endeavor. 
These significant structures permit favorable distribution of local 
anaesthetic that the nerve contact with the block needle is not mandated. 
Successful drug injections   must  always  clarify the borders of the nerve . 
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ULTRASOUND AND ITS ARTIFACTS IN REGIONAL ANAESTHESIA:  
There are several common assumptions in the ultrasound imaging.  First 
of all, the velocity of sound is assumed to be around 1540 msec.  This estimate 
was achieved from measurements   on   soft     tissue at physiological   body 
temperature.  
 When   the    local heterogeneities exist, then artifactual bending of the 
block needle can be seen with sonography, the so-called bayonet artifact.  The 
Speed of sound artifacts relate to the   time-of-flight considerations and to the 
refraction at the interface of tissues with   the different speeds of sound. 
[33,34,35]  
Second thing, sound waves are assumed to take a straight linear   path to 
and from the tissue.  When this does not occur, the reverberation artifacts occur 
from the multipath echoes.  
Then comet tail artifact is a type of reverberation artifact.  At   the   low 
receiver gain, the comet tail is seen as a typical tapering series of discrete and 
clear echo bands just deep to a strongly reflecting structure.  
Then    spacing between the bands represents the distance seen   between 
the anterior and posterior   side   walls of the object.  Internal clear 
reverberations    which     arising from within the object   cause the artifact of 
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comet tail, that   is most intensely observed while   the object is perpendicular to 
the beam.  
Moreover the pleura is a strong reflector that causes the comet tail 
artifact.   Reverberation echoes are   usually    seen  while  strong specular 
reflections are being  received.               
During supraclavicular block, the   mirror-image artifacts can be observed 
from the reverberation.  While  the pleura is adjacent to the subclavian artery, 
the   mirror-image artifacts can occur with gray-scale type  sonographic 
imaging. 
Third to say, all reflectors are assumed to be on one central ray of the 
transducer beam.  When this is not occurring true, out-of-plane artifacts are also   
observed that are slice thickness artifacts. 
Definitive proof  of the   out-of-plane artifacts requires multiple views 
that are recommended when ambiguities arise. 
           Not like the adjacent tissue, biologic fluids is not significantly 
attenuating the sound beam and therefore will   cause acoustic enhancement 
The Acoustic enhancement artifacts deep to vessels may   be erroneously 
interpreted as the nerves. 
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For example, acoustic enhancement  lying   deep to the axillary artery   
that  is  in  the axilla can    mislead .[36-39] 
LOCAL ANAESTHETICS: [25] 
Local  anaesthetics   are  those  drugs   which  on  application   topically    
or  as  a  local  injection   causing  reversible  loss   of  the  sensory  perception, 
specially  to  quote, the  pain, in  a  restricted  area  where  applied  of  the  
body. 
They  block  the  origination  and  also  conduction  of    impulses  
pertaining  to  nerve  mainly  at  all  parts  of  specific  neuron   where  they  
have  come  in  the  contact  without  causing  any  much  structural   damage  to   
the neuron 
Thus  to say, not  only  sensory  impulses  but  motor  impulses  are  also  
interrupted  when  this  drug    is  being  applied  to  a  mixed  nerve, leading  on  
to  muscular  paralysis  and  also  loss  of  the  autonomic  control  too. 
 
MAIN DIFFERENCES BETWEEN THE GENERAL ANAESTHESIA AND 
LOCAL ANAESTHESIA: 
 
• Acting  site  -  CNS  for  GA,  
                             Peripheral nerves for LA  
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• Body  area  involved -  GA – whole  body 
                                     LA - applied area 
• Consciousness  level – lost in GA 
                                     Unaltered  in  LA  
• Care  of  vital  functions – needed in GA  
                                     Not in LA 
• Physiological  alterations – much in GA 
                                     Less in; LA 
• Ill health  patient  -   high risk  for  GA  
                                 Low risk  for  LA  
• Use  in  ill  cooperating  patients – easy  for  GA, not  in LA 
• Major surgery -  GA –preferred  technique 
                                 LA – with some difficulty 
 
The  local  anaesthetics  are  actually  classified  as   
• Amide  group 
• Ester group 
 
The   clinically useful type local 
anesthetic drugs are the weak bases with 
amphiphilic type of property. A 
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hydrophilic  type  of   secondary  or  
tertiary  type  of  amine  nature  on  one  
side  and  a  lipophilic  nature  of  
aromatic residue  on  the  other  side   are  
joined  by  an alkyl  chain together 
Through    an  ester  type  or  amide  type  
linkage. 
 
 
ESTER LINKED TYPE LOCAL ANAESTHETICS: 
• COCAINE 
• CHLOROPROCAINE 
• PROCAINE 
• TETRACAINE 
• BENZOCAINE 
 
AMIDE LINKED LOCAL ANAESTHETICS: 
                  
• LIGNOCAINE 
• BUPIVACAINE 
• DIBUCAINE 
• PRILOCAINE 
• ROPIVACAINE 
26 
 
 
Pka for the local anaesthetics are: 
  
THE  AMIDES  :                           
 
 
Bupivacaine AND       
 
 
 
 
8.1 
Ropivacaine 
 
  
  
Lignocaine  and   
7.8  
Prilocaine  
 
 
Etidocaine  has 7.7 
 
Mepivacaine  has 7.6 
  
 
 
ESTERS  
 
Chloroprocaine  has
 
9.0 
 
Procaine   has 
 
8.9  
 
Cocaine  has 8.7  
 
Tetracaine  has 8.2  
 
FEATURES OF AMIDE LOCAL ANAESTHETICS   ARE FOUND TO BE     
IN CONTRAST TO ESTER TYPE LOCAL ANAESTHETICS. 
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AMIDE  LOCAL  ANAESTHETICS  ARE  SPECIFIC  IN  THIS  
FOLLOWING  SIGNIFICANT  APPRECIATING  FEATURES: 
  
• Produce  much  intense and  a  longer  lasting  anaesthesia  
• Bind  to  the  protein  alpha 1 acid  glycoprotein in  plasma  
• Not  at all  hydrolysed  by  the   enzyme  plasma  esterases 
• Very  rarely  may  cause  hypersensitivity  reactions, no  reported  cross  
sensitivity  has  been  seen  with  ester  type  local  anaesthetics. 
                      
                        
THE MECHANISM OF LOCAL ANAESTHETIC DRUG ACTION: 
 
These   drugs  are  found  to  block  the   conduction of  nerve  impulses  
by  decreasing   the penetration  of  sodium  ions    in  the  period  of  upstroke  
of  the  action  potential. 
And  going  to  the  increased  concentration  level   the  rise  rate  of  
action  potential   and  the  top most  occurring  depolarization reduces  leading  
on  to  the  slowness of  conduction.  
Thus  to  say  here  is   THE  FAILING  OF  LOCAL  
DEPOLARISATION  to   reach  to  threshold  potential   leading  to  the  
ensuing  conduction  interruption.  
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The   predominant   active  species  which  is  the  cationic  form  of  the  
drug  that  is  able  to  go  near  the  receptor  only  if  the  channel  remains  in  
the  open  conformation  at  the  inner  aspect  side, and  too  it  binds  at  
significant  avid  nature  to  the  inactive  conformation  of  the  channel. 
Hence  to   say  here  is,  a resting  conformation  nerve  is   actually  
resistant  to  the  action  of  blocking  and  the  block  action   is  developing  
rapidly  in  repeatedly  being  stimulated  nerve. 
The  frequency  of  this   multiple  stimulation  is  also  a   tribute  factor  
on  which  the   blockade  degree  is  relying.   So the degree of blockade relies   
mainly on   many vital factors. 
Greater level of   blockade quality   has been seen with   higher 
stimulation frequency.  And  moreover   the  exposure  to   a  huge  
concentration  of  calcium  is  actually  seen  to  decrease  the   inactivation  of  
sodium  channels   and   thereby  it  is  lessening  the  degree of   the  block.  
This  process  of  interruption  of  impulses  travel  by  these   local  anaesthetic   
drugs   are  found  to  be  not  mainly  due  to  the  hyperpolarisation  BUT  
INDEED  THE  RESTING  POTENTIAL  OF  THE  MEMBRANE  IS   NOT  
CHANGED  because  the  channels  of  potassium   will  be  getting  blocked  
only  at  a   very  high  local   anaesthetic  level. 
The  initial  time  to  start  block   is  linked  to  the  drug’s  own  status   
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of  p -ka.  Those   drugs with lesser p -ka, to say like  
• Lignocaine 
• Mepivacaine 
are  found  to  be  quicker  initiation  acting, the  reason  for  it  is  near  to thirty  
to  forty  percent  of  that  drug  is  in  the base  form  without dissociation  at  
the  normal  body  level  p-H of  7.4  and  this  exact  form  is  going  to  
penetrate  the  axon. 
 
The  drugs  which  are  actually  found  to  be  having  high  status  of p-
ka namely: 
• Procaine 
• Tetracaine 
• Bupivacaine 
are  really  having  slower  initiation of  action and its  good  reason is  the  
lesser  percent  of  only  fifteen is  in  base  form  without  ionization. 
 
The  one  drug  which  is  really  not  falling  in  this  trap  categorical 
scene  is  chloroprocaine  which  has  quicker  initiation  action  even though it 
is  possessing  a  high  rate  of  p-ka   of  as  high as 9.1. 
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LOCAL ACTIONS OF THE DRUG: 
These drugs   clinically have no or to say minimal   irritant local action. 
They  decrease  the  release  of   acetyl choline  also  from   the  endings  of  
motor  nerve.   
When  it  is  being  injected  around  the  motor or  mixed  nerve  it  will  
produce  anaesthesia  of  skin  and  also  paralysis  of  the  voluntary  muscular  
structure  supplied  by  that  nerve.  The sensory and motor fibres are equally   
having sensitivity profile. 
The   sensitivity  is  determined  by  the  fibre’s  diameter   as well so  as  
what   variety of  fibre  it  is.  usually  the  fibres  that  are  thinner   are  much  
sensitive  than   which  are  in  larger  compared  size.  Another  thing  to  notice  
is   that  the  fibres  that  are  covered  by  myelin  or  sheathed   are  having  
lesser   than  expected    propensity  to  get   blocked  than   when  compared  in  
the  unsheathed  fibres. 
 
Fibres  also  vary  by  the  significant  length  of   axon  which  must  be  
getting  revealed  to  this  drug  to  deliver  an  effective  interruption  of  
impulses  in  the  travelling  propagation. 
The  fibres  which  are  small  are  also  having  a  short  significant   
length   of   axons  because  in    these  fibres  the  alterations  in  the  voltage   
are  travelling  passively  for  compared  short  distances. 
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Another  thing  is  more  thin  axons  are  found  to  be  having   shorter  
distances  of  inter nodes  and  the  drugs   of  local  anaesthetic  variety  enter   
through  the  nodes  of  ranvier  only  in  to  the  axons.  The  sodium  channel  
density   is  very  higher  in  these  specific  sites,  the  so  called  ranvier  nodes. 
It  has  been  noted  already  that  the  block  degree  also  significantly  
rely  on  the  frequency  stimulation.  That  fact  applies  well  here  that  is  
SENSORY  FIBRES  THAT  TOO  THE  SMALLER  TYPES  ARE  VERY  
VULNERABLE   as  they  are  generating  frequency  of  higher  level   with  
longer  sustaining  action  potentials when  contrasted  with  the  motor  fibres. 
When  contrasted  with  the  somatic  fibres, the  autonomic  type  fibres  
are   much  susceptible.  While  being  applied  to  the  tongue, the  taste  sense  
of  bitter  is  found  to  be  lost  first, next  being  followed  there by  the  
sweetness  taste  and  sour  one  and  the  last  to  all   is  the  salty. 
                                   
 
SYSTEMIC ACTION PERTAINED TO THIS DRUG: 
ANY  OF   LOCAL  ANAESTHETIC  DRUG  when  it  is  injected  or  
if  it  is  locally  applied, anyway  ultimately  it  is  being  absorbed  entering  
circulation  and  naturally  producing  the  effects  on  the  vital  systems which  
also  depend  on  the  attained  concentration. 
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The various actions on systems are focused as: 
• Neural  system 
• Cardiac system 
• Vascular territorial  system 
NEURAL SYSTEM: 
All  these  local  acting  drugs  are  producing  continuous  events  of   
stimulation  that  is   sequently  followed  by  depression.  The  powerful  
STIMULATING  drug  on  CNS,  the  so  called  cocaine  drug  -  in  sequence  
it  is  causing.   
• Euphoria 
• Excitedness 
• Confusion  of  mentation 
• Restless  nature 
• Tremor 
• Muscle targeted  twitches 
• Convulsive  events 
• Unconscious  state 
• Depression  of  respiratory  adequacy 
• Finally  - death 
These all   are   seen to be happening in a dose level dependent fashion. 
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Procaine  and  also  other  synthetic  locally  acting  drugs   are  really  
having  much  lesser  potency   as  far  as  this  regard.  At  the  safe  doses  of  
clinical  usage,  they  are  seen  to  produce  vague  apparent    CNS  effects.  
                                     But  on  the   counter  level  scale  to  be  noticeable  
thing  is  that   at  a  higher  level  doses  or  while  it  has  accidentally  reached  
in  to  the    vascular  space,  it  is  found  to  produce  stimulation  of  the  neural  
system   followed  by  the  phenomenon -  depression.  On   to  move  to  other 
drugs  that  is  to  say  on  lignocaine   which  causes  drowsy  state, lethargy  
state --  higher  doses  seen  to  be  producing   stimulation  of  neural  system--- 
then  depression. 
 
CARDIAC SYSTEM ACTION: 
These  are  actually  the  depressing  type  drugs  on  the  cardiac  state.  
But  to  say  is  that  conventionally  administered   dose  levels   -  no  notable  
effects  seen.  Still at high dose levels, or probable reach inside vascular        
Channel, then in cardiac tissue: 
• Automaticity  depressed 
• Excitability  reduced 
• Contractility  blunted 
• Conductivity  slowed 
• Effective period  of  refractoriness  lengthened 
34 
 
 
In  this  aspect   bupivacaine  is    worse  in  cardiotoxic  profile  and  it  is   
notorious  for: 
• Ventricular  level  tachycardia 
• Fibrillation  of  the  ventricles 
 
VASCULAR SYSTEM ACTION OF THE DRUG: 
They  are  in  a  profile  to  produce  the  decline  in  the  blood  pressure  
which  is  mainly    because    of     the   block    of    the  sympathetic  tract  but  
at  the  high  level  dosages, they  are  seen  to  be  causing   direct  stimulated  
relaxation  of  the   smooth   muscular  component  of  the   arteriolar  area.  But  
it  is  to  be  remembering  that   at  doses  of  toxic  reaching  levels ,  it  will  
cause  the  collapse  in  the  cardio vascular  profile . 
 
Procaine and also the   relating drugs   seen to possess: 
• Weaker  anti cholinergic 
• Also  antihistaminic 
• Blocking  action  at   ganglion 
• Blocking  act  at  neuromuscular area 
• Relaxing  effect  on  smooth  muscle 
Though these were of   not much clinical significance. 
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BUPIVACAINE:[25] 
               This  is  a  potent  and  also  long  acting  amide  linked  local  
anaesthetic  drug  which  can  be  used  for  infiltration, nerve  block,epidural  
and  spinal  anaesthesia  of  a  long  duration. A  0.25 to 0.5 % solution  of  drug  
injected  epidurally  resulted  adequate  analgesia  without  that  much  motor  
blockade. And  hence  this  has  become  very  popular  in  obstetrics  ( mother  
can  actively  participate in  vaginal  delivery ) and  thus  used  for  post surgery  
relief  of  pain  by  using  continuous  infusions  epidurally.   
                     This possesses  a  high  lipid  solubility, distributes  high  in  the  
tissues  than  in  the  blood  after  giving  the  subarachnoid / epidural  injections  
and  thereby  these  possesses  a  lesser  chance  of  reaching  the  foetus (when  
being  used  in  labour)  to  produce  neonatal  depression. 
                   This  drug  is  more  liable  to  prolong  the  QTc  interval  and  will  
induce  ventricular  level  tachycardia  or  cardiac  depression  as  already  
mentioned. For  this  reason,  this  should  not  be  used  for  intravenous  
regional  analgesia. Bupivacaine  is  metabolized  in  the  liver. It  provides  
duration  of  nerve  block  to  180 – 360  minutes  without  any  added  
adjuvants.   
                 The R+  enantiomer  Levobupivacaine  is  equally  potent   to  
racemic  bupivacaine  but  less  cardiotoxic  and  also  less  prone  to  cause  
seizures  after  the  accidental  intravascular  entry  of  the  drug. 
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BUPRENORPHINE DRUG: [25] 
This is   actually a synthetic type of drug.  This  is  seen  to  possess  the  
drug  thebaine  as  its  congener.  This is having a higher scale of lipid – fat – 
dissolving   nature.  It   is a mu receptor level action drug.  It is possessing the 
analgesic action.  It  has  twenty  five  times  high  potency  than  morphine  
drug .  
It  has  slower  initiating  action  but  the  total  acting  time  is  longer. 
After  giving  one  dosage, the  time  free  of  pain  is   seen  to  sustain  for  six  
to  eight  hours.  If it  is  used  again  and  multiple  occasions  it  will  provide  
the  time  free  of  pain    to  twenty  four  hours. 
The various   seen side   effects of this drug buprenorphine are mainly: 
• Side  effect  of  sedation 
• Side  effect  of  nausea 
• Side effect of  vomiting 
• Side  effect  of  miosis 
• Subjective  illness 
• Side effects  in  cardiac  system 
• Less marked constipation 
• Side  effect  of  postural  hypotension 
• Depression  of  adequacy  of  respiration 
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This  drug  is   seen  to  be  having   tolerance  at  a  degree  of  lower  status.  
Also  physical  type  of  and  also  the  so  called  psychological  type  of  the  
status  called  dependence   is  also   seen  with  persons  using  the  drug  
buprenorphine  on  a  chronic  scale use. 
The  syndrome  showing  the  different  symptoms  because  of  withdrawing  
from its  use  pertaining  to  buprenorphine  drug  is   somehow  mimicking  like  
the  drug  called  morphine   but  the  clarifying, differentiating  things  from  
that  are: 
• This  may  take  certain  days  to  develop  itself 
• This  is  milder 
• This  is  sustaining symptom for  longer 
• Liability of  nature towards  abuse  rated  less  than morphine 
Naloxone  is  having  ability   to  reverse  its  effects  just  
partially  only  because  the  drug  buprenorphine  is  tightly  
appearing  bound  to  its  receptor . 
 
 This  is  mainly  excreted  in  the  same  unchanged  form  in  the  bile  
secretion,  so  it  naturally  finds  its  way  of  excretion  through   the   faecal  
residue. 
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DOSAGES:  
• Intra muscular  level  administered  as  range  of  from  
0.3 to 0.6 mg   
• Subcutaneous  dose  same as  the  IM  delivery 
• Slow  administering  intravenous  dose same  as  above  
• Sublingually  also  dose is  as  0.2-0.4 mg 
 
USES IN THE CLINICAL ASPECT: 
• CHRONIC  LASTING  PAIN  AS  WITH  THE   
ONCOLOGICALLY  AFFECTED  PATIENTS 
• As  in premedication  
• For  providing  pain freeness  after  surgery 
• Also  in  myocardial  infarction  
 
CLONIDINE DRUG: [25,26] 
This   is actually a derivative of the imidazoline nucleus.  This  drug  is  
related  to  the  drug  called  naphazoline, still  this  has  complex  profile  of  
actions.  This  is  a  partial  level  agonist  with  a  high  level  affinity  and  also  
high  level  intrinsic  activity  at  the  alpha  two  receptors, that  too  in  a   
special  subtype  called  as  the  alpha  two  A   type  of  receptors   in  the  stem   
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of  brain.  This  produces  various  and  major  range  of  effects  on   
haemodynamics  found  to  be  resulting  from  the  stimulation  of  the  alpha  
two   A   receptors  seen  mainly  post junctionally  in  the  vasomotor  site  
centre  in  the  medulla.  This leads  to  the  fall in  the  outflow  of  sympathetic  
throws   and  thereby  fall  in   the  pressure  exerted  on  the  vessel  lateral  
walls. 
This  may  lead  to  bradycardia   also    because  of  the   raise  in  the  
tone   of  the   vagal  territory , thus   the  plasma  holding  level  of   nor 
adrenaline  also  is  declining .   This  has  the  vital potential  to  PREVENT  
the  release  of  NA  directly   from  the  peripheral  sites  still  this  effect   is  
not  so  proving  in    the  doses  of  clinical  use . 
 
UNWANTED EFFECTS OR HARM EFFECTS: 
These  are  of  disturbing  and  of  harming  nature   when  given  for  
clinical  use, to  say  are:  
• Side  effect  of  depressed  mentation  
• Side  effect   of  so  called   sedation  
• Disturbed  nature   of  sleep 
• Dryness of  the  area  of  mouth  and  also  nose , eyes 
• Constipation  due  to  the  anti-secretory  nature  action  on  intestines  
40 
 
• Impotence 
• Retention  of  water  and  salt 
• Bradycardia 
• Hypotension  when  erect  posture  
• If  dose  missed  in  2  days  - threatened  rise  of  pressure  on  lateral 
wall  of  vessel  
• A  syndrome  may  occur  that  is  more  like  pheochromocytoma 
• Tachycardia  if  dose missed 
•  Anxiety  if  dose  missed  
• Headache  also  occurs  if  dose  missed 
 
INTERACTIONS  WITH VARIOUS OTHER PHARMACOLOGICAL  
PREPARATIONS: 
This  drug  may  also  like  other  ones  are  seen  to  be   reacting  with  
other   different   drugs   namely: 
• Tricyclic anti-depressant  drug  
• Chlorpromazine 
Because  of  these  specific  interactions, the  intended  anti-hypertensive  
nature  of  the  drug  may  be  very  much  reduced  and  affected. 
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USES CLINICALLY: 
• In  the  treatment  of  moderate  level  hypertension  especially  in  
a  combined  dose  with   diuretic. 
• In order  to  treat  the  syndrome  associated  with  the  effect  of  
withdrawing  from  using  opioids. 
• Also  having  the  analgesic  activity  which  is  made   use  of   to  
remove  the  pain  of  surgery. 
• Also  as  a  premedication 
• To  treat  the  symptoms  of  vasomotor  effect  of  menopausal  
syndrome. 
• To  treat  the  loose  motions  of  diabetic  neuropathy 
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                         MATERIALS AND THE METHODS 
 
STUDY DESIGN: 
Prospective randomized controlled observer blinded study. 
POPULATION: 
60 patients  
INCLUSION CRITERIA: 
• ASA I, II    
• age 20 to 50   
• unilateral upper limb orthopaedic surgeries 
• both sexes 
BLINDING: 
It is mainly an observer blinded study. 
SAMPLE SIZE- 
GROUP ALLOCATION : 
• Group A (n = 20) – patients receiving 30 ml of 0.3% bupivacaine with   
1 ml of normal saline in supraclavicular    block as CONTROL GROUP 
• Group B (n = 20) – patients receiving 30 ml of 0.3% bupivacaine with 
300 mcg buprenorphine [ 1 ml ] in supraclavicular    block as 
BUPRENORPHINE GROUP 
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• Group C ( n= 20) - patients receiving 30 ml of 0.3% bupivacaine with 
150 mcg clonidine [ 1 ml ] in supraclavicular    block as CLONIDINE 
GROUP 
EXCLUSION CRITERIA: 
• Suspected coagulopathy 
• Infection at the site of block 
• Age less than 20 and more than 50 
• Coexisting  diseases like hypertension, diabetes, seizure disorder, liver 
disease, renal disease, CAHD  
• Patient refusal 
• Allergy to local anaesthetics   and  study drugs 
• Pregnant  women 
• ASA III , IV 
• Bilateral upper limb procedures 
• Pneumothorax even on any one side  
• Pulmonary pathology 
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PRE OPERATIVE EVALUATION: 
In all the patients,  
• age,  
• I.P. No.,  
• body weight, and  
• baseline vital parameters  
were recorded.  
History regarding 
• previous anaesthesia, surgery, 
• any significant medical illness,  
• medications and 
• allergy were recorded.  
Complete   physical   examination and airway assessment   were done. 
Following laboratory investigations were done:  like 
• haemoglobin %, 
• blood sugar & urea,  
• serum creatinine and 
• urine analysis. 
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RANDOMISATION: 
                               The   population  is  allocated  into  these  defined  groups  
according  to  computer  generated  random numbers. 
 
STUDY METHOD: 
After getting institutional level ethical authorized committee level   
permission,   written level    informed, explained consent from the patients, they 
have been    allocated   randomly into 3   as: 
• Group A   taken as control,  
•  B as  Buprenorphine group and 
•  Group C as Clonidine group as mentioned earlier. 
 
All the adults were   given      Inj.Atropine 0.02mg per kilo weight  i.m. 
45 min prior to anaesthesia.  Standard    monitoring   was used during 
anaesthesia and surgery. HR, MAP and SpO2 were recorded before surgery and 
at regular intervals during and after the surgery. 
 
TECHNIQUE: 
After sterile preparation  of  the   neck region, 22 G  hypodermic needle  
of  4  cm  was  used  for  supraclavicular  block   by  paraesthesia  elicitation  
technique as mentioned  in  detail  in the earlier section.  The   SOLUTION    
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was DELIVERED THROUGH THIS NEEDLE checking for   repeated careful 
aspiration for   blood if at all   to prevent   intravascular flow of the drug.  While  
giving  the  drug  was  finished, the  sensory block  was  assessed     by  
sensations  to  pinprick   and   to  evaluate  the  motor blockade,    movements  
in  thumb: 
• adduction for ulnar N,  
• abduction for  radial N,  
• opposition for  median N,  
• flexion of elbow, the   supination  and   the  pronation of   forearm for   
musculocutaneous N  were  assessed. 
Hollmen scale made use of    to examine   sensory as well as motor block. 
Examination was conducted every one minute  after  giving  the  drug   and  the 
time taken for  initiation   of   the  motor  and  sensory  block  was noted.  Time 
for onset   is explained   as level   of at the least   grade 2 in measuring 
hollmen’s scale. 
Time for  complete  block  is   defined  as  while    motor, sensory  scores  
amount   to   grade 3 according  to  hollmen  scale.  Total  time   of  motor  
block   is    explained  to  be  the  time   from the   injection  of    the    drug   
and  recovery  of   muscle power. 
Total  duration  of  sensory  block  is  defined  -- the time  from  giving  
the  drug   and  the  tme  when  complaint  pain  in   the  period   post-surgery. 
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When    intubation and GA needed   for unsuccess of   block or    not an 
adequate block that was excluded from the study. 
Moreover  the  intraoperative  and  post-operative  complications were 
noted  which  is  also  to  be  adequately  seen  and  scored  for  the  necessity  of  
grading  the  drugs. 
 
HOLLMEN SCALE:  
FOR   MOTOR BLOCK: 
Normal level of   function of muscle = 1     
 Mild   level function weakness = 2     
Moderate level function weakness =3                          
total   action of muscle lost = 4  
 
Sensory block assessment:   
          Good   level pinprick sensation = 1     
 perceived   -- pointed sharp weak sensation than other hand = 2 
          Perceived sense- blunt touch with needle=3   
          Nil sensation to pinpriock =4      
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STATISTICAL ANALYSIS:                                    
                                 The Randomised  three groups were matched by  
their demographic factors like 
• age   
• weight     
baseline Physiological factors – 
• pulse rate,  
• MAP and 
• SPO2 
 
By the technique of ANOVA (Analysis of Variance).  The differences 
between them were interpreted by the Post hoc test of Bonferroni.  Similarly, 
the time for sensory block, time for motor block   analysed in the anova 
technique. 
                                                                                                                                           
Intra and post-operative pulse rate, MAP and SPO2 at different intervals  
BEING CLEARLY  ANALYSED  in  the  anova  technique and 
interpreted  difference by Post hoc test of Bonferroni.  The Type of 
Surgery was analyzed and interpreted by χ2 test (Chi- square).   
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The above statistical procedures were performed by the statistical 
package IBM SPSS statistics- 20.  The P – values less than 0.05 (P<0.05) 
were treated as significant in two tail condition.  
 
 
RESULTS: 
 group matching: 
The three groups namely A, B and C were selected with each group 
encorporating 20 subjects.  For randomization the three groups were matched 
according to their selected and related demographic characteristics such as age 
and weight. 
The baseline Physiological characteristics such as pre pulse rate, MAP 
and SPO2 and the type of surgery was also matched. There  were  no  much  
marked  differences  among  these  haemodynamic  variables  prior  to  the  
attempted  procedure.  
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Table -1.  Matching of three groups according to their demographic   
 
characteristics 
                                                    
 
Group 
n Mean S D ANOVA 
’F’ 
df Significance 
AGE 
A 20 34.5 7.4 
 
2.461 
 
2, 57 
 
P>0.05 
B 20 40.1 8.7    
C 20 36.6 8.1    
WEIGHT 
A 20 65.6 4.3 
 
2.994 
 
2, 57. 
 
P>0.05 
B 20 64.3 5.4    
C 20 61.4 6.9    
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Figure - 1. Comparison of age and weight between the three groups 
 
 
 
 
 
                          The demographic variables of three groups were 
matched in the above table -1.  The age and weight of three   analysed   - 
statistically significant difference --nil (P>0.05).   
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Table number 2. Matching of three groups according to their 
physiological   characteristics 
 
Variables 
Group 
n Mean S D ANOVA 
’F’ 
df Significance 
Pre pulse 
rate 
A 20 83.6 4.6 1.136 
 
2, 57 
 
P>0.05 
B 20 81.6 5.5    
C 20 83.4 3.8    
Pre MAP 
A 20 93.4 1.6 
 
0.325 
 
2, 57. 
 
P>0.05 
B 20 93.1 2.5    
C 20 92.9 1.7    
 A 20 97.8 0.6 
 
1.715 
 
 
Pre SPO2 B 20 98.0 0.7      2, 57 P>0.05 
 C 20 98.1 0.4    
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Figure - 2.  Comparison of  baseline  haemodynamic variables. 
 
 
 
 
 
 
 
Haemodynamic variables of three groups before surgery were matched in 
the table-2. 
 
In  this  systematic  process  of  the  matching  analysis,the  
• Pulse rate,  
•  MAP and   
• spo2  were not significantly differed between three groups   
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(P>0.05). 
 
 
 
Table - 3. Matching of the type of Surgery 
 
 
 
     Type of surgery A B C   Total      χ2      df    Sig 
Bone grafting, distal 
locking 
0 0 1 1 
40.871 34 .194 
Buttress plating with k 
wire fixation 
1 0 0 1 
Deroofing & curettage 1 0 0 1 
Implant exit, lrs 
fixation 
0 0 1 1 
Implant exit & im 
nailing 
0 0 1 1 
K wire fixation 1 0 0 1 
Oblique osteotomy & k 
wire fixation 
1 0 0 1 
ORIF with berbert 
screw 
0 1 0 1 
ORIF with DCP 1 1 3 5 
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ORIF with kwire 
fixation 
1 0 0 1 
ORIF with nailing 0 0 1 1 
ORIF with narrow 
DCP 
2 1 2 5 
ORIF with plate 
osteosynthesis 
7 2 1 10 
ORIF with plate 
osteotomy 
0 1 0 1 
Radial head excision 0 1 0 1 
Refixation of k wire 0 0 1 1 
Total 
  Number  of  cases  
20 20 20 60 
     
 
The type of surgery was compared between the groups in table-3.  There 
was no significant association between types of surgery with the groups.  
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Comparison     of    PR,   MAP, &   SPO2 at different time 
intervals between groups: 
 
                                 Table - 4 Comparison of pulse rate between groups at         
 
different time interval. 
 
 
 
Pulse  
Rate at 
Group n Mea
n 
S D F df Sig  (P) 
5 
Minutes 
 A 20 84.4 5.3 1.346 2, 57 .248 
 B 20 82.8 4.4    
 C 20 85.2 3.6    
 
10 
Minutes 
 A 20 84.4 6.0 .494 2, 57 .613 
 B 20 83.4 4.6    
 C 20 84.8 3.9    
 
20 
Minutes 
 A 20 84.8 4.1 .974 2, 57 .384 
 B 20 83.6 4.4    
 C 20 85.3 3.6    
30 
Minutes 
 A 20 85.1 3.4 1.236 2, 57 .298 
 B 20 83.8 4.2    
 C 20 85.5 3.2    
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1 Hour 
 A 20 84.2 4.9 1.576 2, 57 .216 
 B 20 83.5 3.8    
 C 20 85.6 3.0    
2 Hour 
 A 20 84.5 4.6 2.792 2, 57 .070 
 B 20 83.2 4.3    
 C 20 86.2 3.0    
3 Hour  A 20 84.9 3.1 
1.391 2, 57 .257 
 
 B 20 84.0 4.4 
 C 20 85.9 3.5    
4 Hour 
 A 20 85.7 2.6 1.634 2, 57 .204 
 B 20 84.1 4.3    
 C 20 86.0 3.6    
5 Hour 
 A 20 85.5 3.7 1.892 2, 57 .160 
 B 20 83.2 5.0    
 C 20 85.4 3.5    
6 Hour 
 A 20 86.0 3.4 .926 2, 57 .402 
     B 20 84.4 4.6 
 
  
 C 20 85.6 3.8  
 8 Hour 
 A 20 86.0 4.4 .953 2, 57 .392 
 B 20 84.2 4.3    
 C 20 85.4 3.8    
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 12 Hour 
 A 20 85.5 4.5 1.243 2, 57 .296 
 B 20 83.8 4.1    
 C 20 85.7 3.6    
 16 Hour 
 A 20 85.9 4.9 .731 2, 57 .486 
 B 20 84.3 3.9 
 
  
 C 20 85.2 4.0  
 24 Hour 
 A 20 85.5 4.5 .658 2, 57 .522 
 B 20 84.4 3.8    
 C 20 85.8 3.9    
 
 
  The  above  table-4 shows the pulse rate between three groups at 
different time interval.  The pulse rates at different interval     not   significantly 
altering   among     these three (P>0.05). 
 
 
 
Table - 5.  Comparison of MAP between groups at different time interval. 
 
MAP at Group n Mean S D F df Sig  (P) 
5 
Minutes 
A 20 93.6 1.8 
1.539 
 
2, 57 
 
.223 
 
B 20 92.5 2.3 
C 20 92.6 2.2 
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10 
Minutes 
A 20 93.4 4.0 
.103 
 
2, 57 
 
.902 
 
B 20 93.4 1.6 
C 20 93.1 1.4 
 
20 
Minutes 
A 20 92.6 4.4 
.582 
 
2, 57 
 
.562 
 
B 20 93.4 1.8 
C 20 93.6 1.9 
30 
Minutes 
A 20 93.8 0.9 
.487 
 
2, 57 
 
.617 
 
B 20 93.4 1.7 
C 20 93.8 2.2 
1 Hour 
A 20 93.9 1.2 
.885 
 
2, 57 
 
.419 
 
B 20 93.2 1.8 
C 20 93.5 1.6 
Second  
hour 
A 20 93.9 1.6 
.673 
 
2, 57 
 
.514 
 
B 20 93.2 1.9 
C 20 93.6 1.9 
Third 
hour 
 
A 20 93.8 1.6 
.143 
 
2, 57 
 
.867 
 
B 20 93.5 2.9 
C 20 93.8 1.9 
Fourth 
hour 
A 20 93.4 1.6 
1.884 
 
2, 57 
 
.161 
 
B 20 94.0 1.6 
C 20 94.3 1.5 
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Fifth 
hour 
A 20 93.2 2.1 
.630 
 
2, 57 
 
.536 
 
B 20 93.5 2.2 
C 20 93.9 1.6 
6thhour 
A 20 93.1 2.6 
1.764 
 
2, 57 
 
.181 
 
B 20 93.4 1.9 
C 20 94.3 1.7 
Eighth 
hour 
A 20 92.9 2.3 
1.234 
 
2, 57 
 
.299 
 
B 20 93.2 1.7 
C 20 93.9 2.2 
 12 Hour 
A 20 93.4 2.6 
1.007 
 
2, 57 
 
.372 
 
B 20 92.8 1.8 
C 20 93.7 1.6 
 16 Hour 
A 20 93.4 2.9 
.044 
 
2, 57 
 
.957 
 
B 20 93.6 1.6 
C 20 93.6 1.7 
 24 Hour 
A 20 93.4 2.6 
.622 
 
2, 57 
 
.540 
 
B 20 93.8 1.6 
C 20 93.1 16 
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The above table-5 states the MAP at different intervals between the three 
groups. The MAP of three groups were not significantly differing at all intervals 
between them (P>0.05). 
 
Table - 6.   Comparison   of   spo2 between groups at different 
time interval. 
 
 
SPO2 at Group n Mean S D F df Sig  (P) 
5 
Minutes 
A 20 97.4 0.7 
.763 
 
2, 57 
 
.471 
 
B 20 97.6 0.5 
C 20 97.6 0.7 
 
10 
Minutes 
A 20 97.4 0.7 
.808 
 
2, 57 
 
.451 
 
B 20 97.5 0.6 
C 20 97.6 0.6 
 
20 
Minutes 
A 20 97.2 0.7 
2.323 
 
2, 57 
 
.107 
 
B 20 97.5 0.6 
C 20 97.7 0.6 
30 
Minutes 
A 20 97.6 0.6 
.676 
 
2, 57 
 
.513 
 
B 20 97.6 0.7 
C 20 97.8 0.7 
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1 Hour 
A 20 97.5 0.5 
.379 
 
2, 57 
 
.686 
 
B 20 97.5 0.7 
C 20 97.6 0.7 
 2 Hour 
A 20 97.5 0.5 
1.267 
 
2, 57 
 
.290 
 
B 20 97.6 0.7 
C 20 97.8 0.6 
 3 Hour 
 
A 20 97.4 0.5 
2.192 
 
2, 57 
 
.121 
 
B 20 97.8 0.6 
C 20 97.8 0.8 
 4 Hour 
A 20 97.4 0.5 
2.369 
 
2, 57 
 
.103 
 
B 20 97.6 0.6 
C 20 97.7 0.7 
5 Hour 
A 20 97.2 0.4 
2.019 
 
2, 57 
 
.142 
 
B 20 97.5 0.5 
C 20 97.4 0.7 
 6 Hour 
A 20 97.3 0.6 
1.054 
 
2, 57 
 
.355 
 
B 20 97.5 0.5 
C 20 97.6 0.9 
 8 Hour 
A 20 97.5 0.5 
1.144 
 
2, 57 
 
.326 
 
B 20 97.8 0.7 
C 20 97.7 0.7 
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 12 Hour 
A 20 97.5 0.7 
2.019 
 
2, 57 
 
.142 
 
B 20 97.7 0.6 
C 20 98.0 0.8 
 16 Hour 
A 20 97.4 0.8 
1.421 
 
2, 57 
 
.250 
 
B 20 97.7 0.5 
C 20 97.7 0.6 
 24 Hour 
A 20 97.5 0.6 
.868 
 
2, 57 
 
.425 
 
B 20 97.8 0.6 
C 20 97.8 0.7 
   
           
The SPO2 of three groups at   different intervals was shown in the above 
table-6. The observed differences between the three groups at different intervals 
were not   found to be statistically significant (P>0.05). 
 
Comparison of Motor Blocks and Sensory blocks: 
  
The onset, completion,    total    sensory, motor block time   are analysed    
between three. The  initiation times for sensory, motor  blocks of  these  
different   sets   of   population  were  recorded    after  the  procedure   and  
statistically  been  analysed   between   these  groups. 
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Table - 7. Comparison of initiation times for sensory, motor  blocks 
between groups. 
 
Blocks Groups n Mean SD ANOVA 
‘F’ 
df Sig 
(P) 
Significantly 
differed 
groups 
OTSB 
A 20 6.4 0.5 
81.419 
 
2, 
57 
 
.000 
 
B  differed 
with A&C. 
A&C not 
differed. 
B 20 4.8 0.4 
C 20 6.1 0.3 
OTMB 
A 20 4.3 0.5 
609.548 
 
2, 
57 
 
.000 
A&B not 
differed. C 
differed with 
A&B  
B 20 4.0 0.6 
C 20 9.5 
0. 
6 
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Figure - 3. Comparison of onset time for sensory & motor 
block. 
              Onset time in   min  
 
 
 
 
The onset time of Sensory block and Motor blocks were shown in the 
above table -7. The group B significantly differed with A&C in respect of their 
sensory block on set time and it was comparatively quicker (P<0.001). 
       But, the onset time difference was not significant between the groups 
A&C (P>0.05). 
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Regarding the onset time of motor block, the difference between A&B 
groups was not significant (P>0.05). The C group significantly differed with 
A&B groups and it is longer (P<0.001). 
 
Table - 8. Comparison of Time for Complete Sensory and Motor blocks 
between  groups. 
 
 
Blocks Groups n Mean SD ANOVA 
‘F’ 
df Sig 
(P) 
Significantly 
differed groups 
TCSB 
A 20 20.6 1.9 
0.364 
 
2, 
57 
 
.697 
 
All groups did not 
differ 
significantly 
B 20 20.8 3.0 
C 20 21.4 3.6 
TCMB 
A 20 17.8 1.7 
19.866 
 
2, 
57 
 
.000 
A&B not 
differed. C 
differed with 
A&B  
B 20 19.3 2.2 
C 20 22.9 3.5 
 
 
 
The above table shows time for complete Sensory block and Motor 
blocks. In respect of their time for complete sensory block all groups did not 
differ significantly between them (P>0.05).  
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Figure - 4. Comparison of TCSB & TCMB. 
 
 
 
 
 
 
  
 
      Regarding the time for complete motor block, the difference between A&B 
groups was not significant (P>0.05). The C group significantly differed with A 
group (P<0.001) and also differed with B group (P<0.001) and it is 
comparatively longer. 
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Table - 9. Comparison of Total Duration of Sensory and Motor blocks              
 
                            between    the   groups. 
 
 
Blocks Groups n Mean SD ANOV
A ‘F’ 
df Sig 
(P) 
Significantly 
differed groups 
TDSB 
A 
2
0 
330.8 14.5 
208.49 
 
2, 57 
 
.000 
All groups  
differed 
significantly 
B 
2
0 
638.5 19.4 
C 
2
0 
464.5 79.1 
TDMB 
A 
2
0 
313.2 11.9 
2.019 
 
2, 57 
 
.142 
No significant 
differences 
between the groups 
B 
2
0 
330.2 11.8 
C 
2
0 
331.8 13.9 
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Figure - 5. Comparison of  TDMB  &  TDSB 
 
 
 
 
 
Total duration of Sensory and Motor blocks were compared in table -9. In 
respect of TDSB, the three groups significantly differed between them 
(P<0.001). It is longer for B than A and C. 
  It is longer for C than A but less than B. 
 Regarding the TDMB,  
 no significant differences were observed between the groups 
(P>0.05) 
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Comparison of duration of surgery: 
 The durations of surgery between the three groups were compared. 
 
Table - 10. Comparison of surgery duration between the groups. 
 
Groups n Mean SD ANOVA ‘F’ df Significance 
A 20 113.5 16.0 
2.029 
 
2, 57 
 
 
p>0.05 B 20 108.3 13.7 
C 20 117.5 13.9 
    
 
Figure - 6.  Comparison of DURATION OF SURGERY  
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The above table-10 compares the duration of surgery between three 
groups.  The durations were not significantly different between the three groups 
(P>0.05). 
 
DISCUSSION: 
In  our  study  5 cases  had  failed  block  and  they  were  eliminated  
from the  study.  The mean ages of A, B, and C groups were 34.5±7.4, 40.1± 8.7 
and 36.6±8.1 years respectively. They did not differ between them 
significantly(P>0.05).  The mean weights of three groups were 65.6±4.3, 
64.3±5.4 and 61.4±6.9 Kgs respectively. The weights of the three groups were 
not significantly different (P>0.05).  
The pre pulse rates of three groups namely A, B, and C were 83.6 ± 4.6, 
81.6±5.5 and83.4±3.8 respectively.  Even fortunately the  sex  ratio  of  each  
group  were  also  similar  making  the  matching  unnecessary.  The pre MAP 
were 93.4 ± 1.6, 93.1±2.5and 92.9±1.7 respectively.  
The Pre SPO2 was 97.8±0.6, 98.0±0.7 and 98.1±0.4 respectively. The pre 
Physiological variables between the three groups were not significantly 
different. Hence, the three groups were comparable groups. 
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The intra and post-operative pulse, MAP and SPO2  of three groups at different 
time interval like 5 Minutes, 10 Minutes, 20 Minutes, 30 Minutes, 1 Hour, 2 
Hours,  3 Hours,  4 Hours, 5 Hours, 6 Hours, 8 Hours,  12 Hours,  16 Hours 
and 24 Hours were analysed statistically.  The pulse, MAP and SPO2 recorded 
in the above time were not significantly different (P>0.05).  
 The onset time of sensory blocks of A group was 6.4 ±0.5 minutes, B 
group was 4.8±0.4 and C group was 6.1±0.3 minutes.  The OTSB of B group 
was significantly lower than A & C groups (4.8±0.4 < 6.4 ±0.5& 6.1±0.3 and 
P<0.05).  The onset time of motor blocks of A group was 4.3± 0.5, B group 
was 4.0 ±0.6 and C group was 9.5±0.6 minutes.  
The OTMB of C group was significantly higher than A&B groups 
(9.5±0.6 > 4.3± 0.5 &4.0 ±0.6 and P<0.05).The  above  findings  have  differed  
from  the  observations  of  the  study  conducted  by  Jadon et al in  which   the  
onset  time  of  motor  block  alone  is  hastened  by  adding  buprenorphine  
but  the  onset  time  for  sensory  block  was prolonged. [23]                               
The Time for Complete Sensory Block of A group was 20.6 ±1.9, B 
group was 20.8±3.0 and C group was 21.4±3.6 minutes.  The TCSB of three 
groups were not significantly different (20.6 ±1.9=20.8±3.0=21.4±3.6 and 
P>0.05).  The Time for Complete Motor Block of A group was 17.8 ± 1.7, B 
group was 19.3± 2.2 and C group was 22.9 ± 3.5 minutes.  
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The TCMB of C group was significantly higher than A&B groups (22.9 
± 3.5> 17.8 ± 1.7&19.3± 2.2 and P<0.05 
The Total Duration of Sensory Block of A group was 330.8 ±14.5, B 
group was 638.5 ± 19.4 and C group was 464.5± 79.1minutes.  The TDSB of B 
group was significantly longer than the C and C longer than A groups (638.5 ± 
19.4> 464.5± 79.1>330.8 ±14.5 and P<0.001).   
The Total Duration of Motor Block of A group was 313.2±11.9, B group 
was 330.2 ± 11.8 and C group was 331.8± 13.9 Minutes and thus did not differ 
significantly. 
The Durations of surgery between the three groups were not significantly 
different and hence they were equal (113.5±16.0 ≈ 108.3±13.7 ≈ 117.5±13.9 
and P>0.05).   
Adverse  effects  were  also  watched  for  in  all  the  three  groups  and  
no significant, serious  effects  were  found  except  for nausea in one  case  in 
the B group which  is  not  significant.   
From the above results and discussions, by considering the non-
significant variations of PR, MAP and SPO2, the significant longer duration of 
TDSB and shorter onset time for motor and sensory block, the  group B is 
considered as better than the other two groups.  
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Bazin et al, had observed a similar duration of analgesia (median 20 
hrs) on buprenorphine administration. In a similar way Candido et al has 
observed duration   of   analgesia   produced   with buprenorphine 3 times 
longer than that produced by local anaesthetics alone.  
Wajima et al has also found satisfactory and prolonged   analgesia    with 
butorphanol administered as   continuous intra brachial   infusion. The 
prolonged   analgesic duration observed   with buprenorphine   may be 
attributed to its high   affinity for the mu opioid    receptor and   its   high   lipid 
solubility. 
This factor   favours easy penetration through the axonal   myelin and nerve 
membrane.  The other factor   that   might   have   influenced    the     protracted     
analgesia of   buprenorphine,   was   
• its potency .  
• Buprenorphine   is    33   to  35  times   more potent   than   morphine.                     
       
Side effects: 
In our study   no major adverse effects have been noted.  Though  some  
studies  have  reported  side  effects  of  bradycardia  with  clonidine, there  
were  no  significant  changes  in  the  blood  pressure  or  heart  rate  in  the  
clonidine  group  as  well  as  in  the  buprenorphine  group.  And  there  were  
no  complaints  of  nausea  and  vomiting  except  one in  buprenorphine  group.  
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SUMMARY:      
Onset time for sensory block     
It is shorter in buprenorphine group than the other groups. 
Onset time for motor block    
It  is  similar  in the  control and buprenorphine  group  but  it  is  longer 
in clonidine  group  than  the  other groups . 
Time for complete sensory block    
This came out as similar in all the groups. 
Time for complete motor block     
It  is  found  to  be  longer  in  clonidine  group than the  other  2  groups  
which  have  similar  TCMB. 
Total duration of motor block   -  
It is almost similar in all the groups.  
Total duration of sensory block    
Buprenorphine  group  has  the longest  duration of  sensory  block  then  
comes  the clonidine  group  and  then the control group. 
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CONCLUSION: 
 
We conclude from this randomized controlled study that buprenorphine   
• hastens the onset of sensory block, 
•  significantly  prolongs  the  duration  of  analgesia     
compared  to   clonidine   
• without  any significant effect on  onset of motor 
block  and  duration of motor block  and  
• without any significant  adverse effects. 
                 
                                       Hence   it  is  clear  from this study that  
buprenorphine  is  a better adjuvant than clonidine  in  supraclavicular  
brachial  plexus  block. 
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PROFORMA             
 
 
Case NO-                       I.P-no-                
 
 
 NAME AND ADDRESS OF THE PATIENT 
 
 
 
Age- :                   Sex                  D.O.ADMISSION 
 
 
History in brief- 
 
 
 
Clinical diagnosis/ indication. 
 
 
 
Examination in brief- 
 
 
A. Vitals 
 a. Pulse               b .B.P-                    C.AIRWAY-ASSESSMENT 
 
B. Systemic examination            
                                        
 
Baseline haemodynamics : 
 
PR:                       BP:                     SPO2: 
 
INVESTIGATIONS                 
Hb%            BT            CT                Blood urea            Serum creatinine                                 
RBS 
Urine examination-                Albumin            Sugar                  Microscopy 
 
Chest X-ray                            ECG                            ASA Grading- 
 
Surgical procedure                  
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Informed written consent. 
 
Name of the patient-                                        I.P. no- 
 
I ,------------ in my  full sense   give   my    wholehearted   consent  for the  
surgery   under brachialplexus block with clonidine and buprenorphine  for 
study  purpose. I agree that no responsibility will be attached to the surgeon or 
anaesthetist. I have been explained about the procedure in my own language. 
                
 
                                 signature of the patient / 
guardian 
 
PROCEDURE—supraclavicular block  
 
PARAMETERS OBSERVED- 
1. onset time for sensory block OTSB 
2. onset time for MOTOR block OTMB 
3. time for complete sensory block 
4. time for complete motor block 
5. total duration of sensory block 
6. total duration of motor block 
 
Intra op &Postoperative Monitoring: 
 
 
Time after block  Heart  rate   Blood pressure            Spo2 
    
    
    
    
    
    
    
    
    
 
Side Effects 
                      Nausea +/- 
                      Vomiting +/- 
                      Drowsiness +/- 
                      Pruritis +/- 
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GROUP A 
S.N
O 
AG
E 
SE
X 
W
T  TYSURG 
BASE LINE  PULSE RATE  MAP 
 
P
R 
MA
P 
SPO
2 
5
M 
10
M 
20
M 
30
M 
1
H 
2
H 
3
H 
4
H 
5
H 
6
H 
8
H 
12
H 
16
H 
24
H 
5
M 
10
M 
20
M 
30
M 
1
H 
2
H 
1  32  F  58 
oblique osteotomy & k 
wire fixation  76  90  99  72  70  76  78  72  73  79  80  76  77  74  73  72  73  90  82  80  93  93  92 
2  38  M  65 
ORIF with plate 
osteosynthesis  86  96  98  89  88  86  87  89  88  83  89  89  87  90  83  89  83  96  95  94  94  95  96 
3  34  M  70  ORIF with DCP  87  95  98  88  89  88  87  85  86  84  87  87  89  88  87  87  87  95  96  94  95  95  96 
4  24  M  68  ORIF  80  96  97  86  82  85  84  86  87  88  87  84  86  88  87  89  87  98  97  96  95  96  96 
5  33  M  70  ORIF with asian DCP  86  93  98  86  88  87  86  85  90  89  88  89  87  88  88  86  88  93  94  95  96  93  93 
6  21  M  66 
ORIF with plate 
osteosynthesis  79  93  98  79  78  78  80  80  80  81  83  84  84  83  84  85  84  93  94  93  94  95  95 
7  33  M  67  ORIF with narrow DCP  80  94  97  80  82  84  86  84  84  84  83  83  88  88  87  86  87  94  95  94  94  94  94 
8  50  M  69 
ORIF with plate 
osteosynthesis  80  92  97  84  85  86  84  84  84  85  85  85  86  87  87  87  87  92  91  91  93  93  93 
9  28  M  65 
ORIF with plate 
osteosynthesis  89  94  97  88  87  87  87  87  87  88  88  89  89  89  87  88  87  94  95  94  94  94  94 
10  43  M  71  k wire fixation  89  93  97  88  89  87  88  89  87  88  88  87  87  88  89  89  89  93  94  95  93  92  92 
11  40  M  69 
ORIF with plate 
osteosynthesis  88  94  98  89  88  87  88  86  86  86  86  88  89  87  87  87  87  94  95  94  93  93  92 
12  29  M  65  ORIF with asian DCP  86  94  97  87  88  88  89  89  87  88  87  88  87  87  88  89  88  94  95  94  93  93  94 
13  33  M  68 
ORIF with plate 
osteosynthesis  80  93  98  86  88  87  86  86  87  86  87  87  86  88  88  89  88  93  94  94  94  95  95 
14  37  M  65  deroofing & curettage  86  93  98  84  85  86  84  84  84  85  85  85  86  87  87  87  87  94  95  94  94  94  94 
15  25  F  55  ORIF  87  95  98  88  89  88  87  85  86  84  87  87  89  88  87  87  87  95  96  94  95  95  96 
16  34  M  60 
buttress plating with k wire 
fixation  79  93  98  79  78  78  80  80  80  81  83  84  84  83  84  85  84  93  94  93  94  95  95 
17  39  M  65  ORIF with asian DCP  76  90  99  72  70  76  78  72  73  79  80  76  77  74  73  72  73  90  82  80  93  93  92 
18  34  M  66 
ORIF with plate 
osteosynthesis  89  93  97  88  89  87  88  89  87  88  88  87  87  88  89  89  89  93  94  95  93  92  92 
19  34  M  70  ORIF with narrow DCP  80  93  98  86  88  87  86  86  87  86  87  87  86  88  88  89  88  93  94  94  94  95  95 
20  48  M  60  ORIF with kwire fixation  88  94  98  89  88  87  88  86  86  86  86  88  89  87  87  87  87  94  95  94  93  93  92 
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GROUP A continued 
MAP  SPO2  MIN 
3
H 
4
H 
5
H 
6
H 
8
H 
12
H 
16
H 
24
H 
5
M 
10
M 
20
M 
30
M 
1
H 
2
H 
3
H 
4
H 
5
H 
6
H 
8
H 
12
H 
16
H 
24
H 
OTS
B 
OTM
B 
TCS
B 
TCM
B 
DO
S 
TDM
B 
TDS
B 
91  90  88  86  87  87  86  87  99  96  97  98  97  98  98  98  98  98  98  99  99  99  6  4  18  15  105  330  345 
96  94  95  94  95  96  96  96  98  98  99  99  98  98  98  97  97  97  97  98  97  98  7  4.5  23  16  110  300  331 
96  96  95  95  95  96  96  96  98  97  97  97  98  97  97  98  97  97  97  98  98  98  7  4  19  20  120  315  340 
96  96  96  95  94  95  96  95  97  97  97  97  97  98  97  98  97  98  98  97  97  97  6  4  22  19  90  320  335 
93  94  94  94  95  95  93  95  98  98  97  97  97  97  98  97  97  98  98  97  97  97  5.5  4  21  18  120  315  330 
95  94  93  93  93  94  95  94  97  98  98  98  98  98  98  97  97  97  97  97  96  97  6  5  20  17  110  310  345 
95  93  93  94  94  95  95  95  97  98  97  97  97  97  97  97  97  98  98  98  97  98  6.5  4  18  17  105  330  300 
93  93  93  93  93  92  91  92  96  97  97  97  97  97  97  97  98  98  98  98  98  98  6.5  4  22  18  105  330  300 
93  93  93  94  94  95  95  95  98  98  98  97  97  97  98  97  97  98  98  98  97  98  6.5  5  21  19  120  315  340 
92  92  93  92  92  91  93  91  97  97  97  98  98  98  98  98  97  97  98  97  98  97  6  4  20  15  135  300  330 
93  93  93  94  92  94  93  94  97  97  98  98  98  98  97  97  97  96  97  97  97  97  6  4  23  20  135  300  330 
94  93  96  95  95  94  94  94  97  98  97  98  98  97  97  97  97  97  97  97  96  97  6.5  5  19  20  120  315  340 
94  94  94  95  93  94  94  94  97  98  96  97  97  97  97  97  97  97  97  97  98  97  7  5  22  18  110  300  330 
95  93  93  94  94  95  95  95  97  98  97  97  97  97  97  97  97  98  98  98  97  98  6.5  4  18  15  70  330  300 
96  96  95  95  95  96  96  96  98  97  97  97  98  97  97  98  97  97  98  98  98  98  7  4  20  16  120  315  340 
95  94  93  93  93  94  95  94  97  98  98  98  98  98  98  97  97  97  98  97  96  97  6  5  21  19  110  310  345 
91  90  88  86  87  87  86  87  99  96  97  98  97  98  98  98  98  98  98  99  99  99  6  4  23  17  105  330  345 
92  92  93  92  92  91  93  91  97  97  97  98  98  98  98  98  97  97  97  97  98  97  6  4  22  20  135  300  330 
94  94  94  95  93  94  94  94  97  98  96  97  97  97  97  97  97  97  97  97  98  97  7  5  22  19  110  300  330 
93  93  93  94  92  94  93  94  97  97  98  98  98  98  97  97  97  96  97  97  97  97  6  4  18  18  135  300  330 
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GROUP B 
S.N
O 
AG
E 
SE
X 
W
T  TYSURG 
BASE LINE  PULSE RATE  MAP 
 PR 
MA
P 
SPO
2 
5
M 
10
M 
20
M 
30
M 
1
H 
2
H 
3
H 
4
H 
5
H 
6
H 
8
H 
12
H 
16
H 
24
H 
5
M 
10
M 
20
M 
30
M 
1
H 
2
H 
1  45  M  68  ORIF  75  100  99  79  78  77  76  76  75  76  79  77  80  82  78  79  79  98  97  98  97  95  96 
2  31  M  67  ORIF  88  95  98  89  88  87  89  88  88  89  89  89  89  89  89  89  89  95  96  96  96  97  96 
3  50  M  66  ORIF with asian DCP  70  93  97  76  75  76  78  78  79  78  76  72  77  76  76  78  79  93  93  94  94  95  96 
4  46  M  70  ORIF  86  96  98  87  88  89  88  88  88  87  88  89  86  86  86  86  87  94  94  95  95  96  95 
5  22  M  60 
ORIF with berbert 
screw  87  88  98  87  86  86  86  86  87  87  87  88  88  88  87  86  86  97  96  97  97  96  98 
6  40  M  70  ORIF with asian DCP  79  93  99  80  82  87  87  88  89  87  86  86  86  86  86  89  89  92  93  93  94  93  93 
7  41  M  60  ORIF  80  95  99  84  86  84  85  83  83  89  89  87  87  88  85  84  84  93  94  93  92  92  91 
8  50  M  66  ORIF  76  92  97  79  78  80  83  82  81  83  84  79  78  78  78  85  84  90  93  94  94  93  92 
9  45  M  50 
ORIF with plate 
osteosynthesis  85  90  97  86  87  85  84  84  84  85  83  82  88  85  86  86  87  90  92  91  93  91  92 
10  47  M  60  ORIF  88  93  98  85  87  87  86  85  84  85  85  86  87  87  87  88  85  93  92  92  92  94  93 
11  40  F  60  ORIF  86  92  98  87  87  88  88  87  86  86  87  87  88  88  87  86  88  90  91  92  92  93  93 
12  38  F  55 
ORIF with plate 
osteosynthesis  77  94  98  76  78  79  78  80  78  78  78  78  79  80  82  79  79  92  94  93  92  91  92 
13  21  M  66  ORIF  86  92  98  86  87  87  87  87  89  88  88  88  89  87  87  87  87  92  93  92  93  92  92 
14  35  M  68  ORIF with narrow DCP  76  93  98  78  77  76  76  76  76  76  77  78  78  78  78  76  77  93  94  93  92  93  93 
15  30  M  68  ORIF with DCP  80  95  99  84  86  84  85  83  83  89  89  87  87  88  85  84  84  93  94  93  92  92  91 
16  50  M  66  ORIF  76  92  97  79  78  80  83  82  81  83  84  79  78  78  78  85  84  90  93  94  94  93  92 
17  40  M  68  ORIF  85  90  97  86  87  85  84  84  84  85  83  82  88  85  86  86  87  90  92  91  93  91  92 
18  50  M  70 
ORIF with plate 
osteotomy  88  93  98  85  87  87  86  85  84  85  85  86  87  87  87  88  85  93  92  92  92  94  93 
19  40  M  66  radial head excision  86  92  98  87  87  88  88  87  86  86  87  87  88  88  87  86  88  90  91  92  92  93  93 
20  40  M  62  ORIF  77  94  98  76  78  79  78  80  78  78  78  78  79  80  82  79  79  92  94  93  92  91  92 
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GROUP B continued 
MAP  SPO2  MIN 
3
H 
4
H 
5
H 
6
H 
8
H 
12
H 
16
H 
24
H 
5
M 
10
M 
20
M 
30
M 
1
H 
2
H 
3
H 
4
H 
5
H 
6
H 
8
H 
12
H 
16
H 
24
H 
OTS
B 
OTM
B 
TCS
B 
TCM
B 
DO
S 
TDM
B 
TDS
B 
95  96  97  97  98  98  98  97  97  96  97  97  97  97  98  98  98  98  98  97  97  97  4  3.5  17  16  130  330  645 
96  96  95  94  95  95  96  96  97  98  98  98  98  98  98  98  98  98  98  98  98  98  4.25  3.75  18  18  110  315  630 
96  93  94  94  95  94  95  96  98  98  97  98  98  97  98  99  98  98  98  98  98  98  3.5  2.5  20  20  105  345  660 
96  96  96  96  94  95  96  96  98  98  98  98  97  97  97  97  97  98  98  98  99  98  5  4.75  25  22  115  330  615 
98  94  97  94  93  93  94  95  97  98  98  98  98  98  98  98  98  97  97  97  97  98  4.75  3  26  21  120  345  645 
94  95  95  94  93  93  93  93  98  98  99  99  98  98  98  98  97  98  99  98  98  98  4.5  3.5  19  17  120  345  660 
94  95  96  96  94  92  93  91  98  98  98  99  99  98  98  98  98  98  99  99  98  98  5  4  22  19  100  315  615 
92  92  91  93  92  92  91  93  97  97  97  97  97  97  97  97  97  98  98  97  97  97  4.75  3.75  21  20  100  330  630 
92  92  92  92  92  90  93  94  98  97  97  97  97  97  97  97  97  98  98  98  98  98  5  4  23  21  90  315  630 
95  96  90  90  91  93  93  93  98  97  97  97  97  97  98  98  98  97  97  98  98  97  5.25  4.75  25  22  100  345  670 
93  92  93  93  94  92  94  94  97  97  97  97  97  99  98  98  98  97  98  98  98  99  5  4.25  18  17  135  340  615 
93  94  94  94  93  92  93  94  98  98  98  98  98  98  99  97  97  97  97  97  97  98  5.25  4.75  17  18  100  330  660 
83  93  91  92  91  94  93  93  98  98  97  97  97  97  97  97  97  97  97  97  97  98  4.75  3.75  18  16  90  330  630 
94  94  93  92  92  92  94  93  97  98  98  98  97  98  98  98  97  97  98  98  98  97  5  4  25  16  120  315  645 
94  95  96  96  94  92  93  91  98  98  98  99  99  98  98  98  98  98  99  99  98  98  5  4  20  22  100  315  615 
92  92  91  93  92  92  91  93  98  97  97  97  97  97  97  97  97  98  98  97  97  97  4.75  3.75  22  21  105  330  630 
92  92  92  92  92  90  93  94  98  97  97  97  97  97  97  97  97  98  98  98  98  98  5  4  18  17  90  315  630 
95  96  90  90  91  93  93  93  98  97  97  97  97  97  98  98  98  97  97  98  98  97  5.25  4.75  18  22  100  345  670 
93  92  93  93  94  92  94  94  97  97  97  97  97  99  98  98  98  97  98  98  98  99  5  4.25  20  20  130  340  615 
93  94  94  93  93  92  93  94  98  98  98  98  98  98  99  97  97  97  97  97  97  98  5.25  4.75  24  21  105  330  660 
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H 
1  25  F  55  ORIF with narrow DCP  86  89  98  86  87  88  87  87  87  87  87  88  88  88  87  88  88  88  90  92  92  91  90 
2  23  M  60 
bone grafting , distal 
locking  88  90  98  87  87  87  88  87  87  87  88  87  87  88  89  88  89  90  92  93  91  92  93 
3  43  F  50  ORIF with DCP  82  92  98  83  84  82  84  85  87  88  87  85  84  84  82  85  83  92  93  94  90  91  92 
4  38  M  60  ORIF with DCP  86  95  98  88  87  89  89  89  89  90  89  89  89  90  89  88  88  95  94  98  99  97  98 
5  30  M  70  ORIF with asian DCP  81  97  98  87  86  85  85  84  86  86  87  87  88  89  88  89  89  96  95  95  95  96  96 
6  32  M  60  ORIF  88  94  98  88  89  89  89  88  87  87  87  86  86  86  88  87  88  96  95  96  94  94  94 
7  45  M  66  ORIF with asian DCP  80  93  98  87  84  85  86  86  87  87  86  85  85  86  86  85  88  94  93  92  96  95  95 
8  40  M  68  ORIF  85  94  99  85  87  86  86  87  87  87  89  88  88  84  84  85  85  93  94  94  95  93  92 
9  44  M  70  ORIF with asian DCP  79  92  98  79  80  83  82  81  80  79  78  78  78  77  80  76  78  92  93  94  93  93  92 
10  45  M  65  ORIF with DCP  86  93  98  88  86  87  87  88  89  87  87  87  89  88  89  88  88  92  93  93  94  94  94 
11  38  M  70 
ORIF with plate 
osteosynthesis  88  92  99  87  86  86  87  87  88  88  89  87  87  88  89  89  90  90  93  92  92  93  94 
12  50  M  60  ORIF with narrow DCP  76  92  98  78  76  76  78  80  82  78  79  78  79  80  82  83  81  92  91  95  96  94  93 
13  49  M  70 
implant exit & im 
nailing  87  93  98  87  88  89  87  88  88  89  89  89  90  89  88  87  86  90  92  94  95  95  95 
14  28  M  60  ORIF  78  94  98  78  76  77  78  79  80  82  83  83  80  82  78  78  78  92  91  90  91  92  92 
15  40  M  50  ORIF with nailing  86  92  97  88  88  87  87  87  89  90  88  87  87  87  88  87  89  93  94  90  92  91  96 
16  35  M  68  ORIF  82  94  98  88  89  89  89  88  87  87  87  86  86  86  88  87  88  96  95  96  94  94  94 
17  33  M  60  refixation of k wire  80  93  98  87  84  85  86  86  87  87  86  85  85  86  86  85  88  94  93  92  96  95  95 
18  26  M  55  implant exit , lrs fixation  85  94  99  85  87  86  86  87  87  87  89  88  88  84  84  85  85  93  94  94  95  93  92 
19  29  M  60  ORIF  79  92  98  79  80  83  82  81  80  79  78  78  78  77  80  76  78  92  93  94  93  93  92 
20  38  M  50  ORIF  86  93  98  88  86  87  87  88  89  87  87  87  89  88  89  88  88  92  93  93  94  94  94 
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GROUP C continued 
MAP  SPO2  MIN 
3
H 
4
H 
5
H 
6
H 
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H 
12
H 
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H 
24
H 
5
M 
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M 
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M 
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M 
1
H 
2
H 
3
H 
4
H 
5
H 
6
H 
8
H 
12
H 
16
H 
24
H 
OTS
B 
OTM
B 
TCS
B 
TCM
B 
DO
S 
TDM
B 
TDS
B 
90  93  92  93  89  92  91  93  98  97  98  98  97  99  99  98  98  98  98  98  98  99  6  10  15  22  115  330  420 
93  92  92  93  93  94  92  92  97  98  98  97  98  98  97  97  97  98  98  98  98  99  6.5  9  25  25  130  330  435 
93  94  94  93  94  93  92  93  98  97  97  97  97  98  98  98  98  98  98  98  98  98  6.5  9.5  20  28  135  345  460 
97  97  96  93  98  98  97  98  99  98  99  98  98  98  99  99  98  98  98  98  98  98  6  9.25  22  23  90  345  405 
95  97  96  93  94  96  95  95  97  98  98  98  98  98  97  97  98  98  98  99  99  99  5.5  10  25  24  110  315  510 
95  96  95  93  96  94  96  95  97  97  98  98  97  98  98  98  98  99  99  99  98  98  6.25  9.5  26  26  130  330  450 
95  95  94  93  93  93  92  92  98  98  98  99  98  98  97  98  97  97  97  97  97  97  6.5  9  27  27  125  315  645 
94  95  95  93  96  94  93  92  97  98  98  98  97  97  99  97  97  97  97  98  98  99  6  9.5  16  28  125  345  435 
91  94  92  93  91  91  93  92  97  97  97  97  98  98  98  99  96  96  97  97  98  98  6.25  9.75  19  25  120  315  440 
93  94  95  93  95  95  95  94  98  99  97  97  97  97  98  98  98  98  98  99  97  97  6.5  8.5  25  23  90  330  405 
93  92  91  93  92  93  95  93  97  98  98  98  98  98  99  97  97  97  97  97  97  97  5.75  9.5  20  22  110  315  450 
93  93  96  93  97  95  93  92  98  97  97  97  98  98  97  99  99  99  99  98  98  98  6  9.75  22  25  135  350  600 
96  93  92  93  93  94  93  92  99  98  98  98  97  97  98  98  97  97  97  97  97  97  5.75  8.75  16  15  125  330  500 
93  93  93  93  93  93  93  93  97  97  97  99  99  99  97  97  97  97  98  99  99  98  6  11  18  18  130  360  400 
97  94  95  93  93  92  92  92  97  98  98  98  97  97  97  97  97  98  98  98  98  97  5.75  10  19  20  120  345  360 
95  96  95  93  96  94  96  95  99  97  97  98  99  98  98  98  98  99  99  99  98  98  6.25  9.5  21  22  120  330  450 
95  95  94  93  93  93  92  92  97  98  99  99  98  98  97  97  97  97  97  97  97  97  6.5  9  22  18  115  315  645 
94  95  95  93  96  94  93  92  97  98  98  98  97  97  99  97  97  97  97  98  98  97  6  9.5  20  19  115  345  435 
91  94  92  93  91  91  93  92  98  97  97  97  98  98  97  98  96  96  97  97  97  98  6.25  9.75  24  22  120  315  440 
93  94  95  93  95  95  95  94  97  98  97  97  97  97  98  98  98  98  98  99  97  97  6.5  8.5  25  25  90  330  405 
 
 
 
 
